This story was originally posted on April 27.

Dutch microarray company PamGene recently announced three new distribution agreements, tapping Cronus Technologies to represent it in the UK and Ireland, Bucher Biotec to sell its products in Switzerland, and Dichrom to cover Germany and Austria. And, according to its managing director, PamGene expects more of such deals in coming months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.